Trihydrogen [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-), compound with N,N'-di(o-tolyl)guanidine (1:3)

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Type of information:

experimental study

Adequacy of study:

key study

Study period:

From 2017-05-16 to 2017-06-23

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Trihydrogen [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-), compound with N,N'-di(o-tolyl)guanidine (1:3)

EC Number:

277-086-3

EC Name:

Trihydrogen [29H,31H-phthalocyaninetrisulphonato(5-)-N29,N30,N31,N32]cuprate(3-), compound with N,N'-di(o-tolyl)guanidine (1:3)

Cas Number:

72928-60-0

Molecular formula:

C32H16-τN8Cu(SO3C15H18N3)τ

IUPAC Name:

Bis and tris and tetra [N-(2-methylanilino)-N’-(2-methylanilino) methaniminium][phthalocyaninesulfonato-κ4N29,N30,N31,N32]cuprate(II)

Test material form:

solid: particulate/powder

Specific details on test material used for the study:

STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature

Method

Species / strain

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Metabolic activation system:

S9 microsome fraction preapred from Sprague Dawley rat liver homogenate provided by MOLTOX

Test concentrations with justification for top dose:

Neither original solutions nor dilutions have bacteriostatic effect.
The test item is tested at these doses (5000, 1500 ,500, 150, 50 µg/plate).

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: Ethanol
(stock solution of the test item prepared at 100mg/ml in Ethanol)

Controls

Untreated negative controls:

yes

Remarks:

vehicle used to solubilize the test item (ethanol)

Negative solvent / vehicle controls:

yes

Remarks:

solvent used to solubilize positive controls (NaCl 0.9%, acetone, DMSO)

True negative controls:

yes

Remarks:

absolute negative control containing no test item corresponding to the spontaneous reversion rate

Positive controls:

yes

Positive control substance:

9-aminoacridine

2-nitrofluorene

sodium azide

other: 2-anthramine

Details on test system and experimental conditions:

METHOD OF APPLICATION: under the direct incorporation of agar medium plate and the pre-incubation procedures

DURATION
- Preincubation period: 30 min at 37°C when the pre-incubation procedure is used.
- Exposure duration: 48-72 h at 37°C
- Expression time (cells in growth medium): ): counting completed at the end of the exposure period in each plate


NUMBER OF REPLICATIONS: Triplicate, in parallel with negative and positive controls and the solvent of test material.


DETERMINATION OF CYTOTOXICITY
- Method: decrease in the number of revertant colonies or a clearing or diminution of the background lawn.

Evaluation criteria:

A positive result involved taking into account a dose-response effect in the range tested and/or a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation system.
The result is considered positive whenever the number of revertants of the test item treated plates is higher than those observed in the solvent treated plates, according to the following criteria:
- TA98 strain : 2 fold higher
- TA100 strain: 2 fold higher
- TA1535 strain : 3 fold higher
- TA1537 strain : 3 fold higher
- WP2 (pkM101) : 2 fold higher

The biological relevance of the results was also considered.

Statistics:

no static used

Results and discussion

Test results

Test results 1

Key result

Species / strain:

S. typhimurium TA 1535

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 2

Key result

Species / strain:

S. typhimurium TA 1537

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 3

Key result

Species / strain:

S. typhimurium TA 98

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Test results 4

Key result

Species / strain:

S. typhimurium TA 100

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

no cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Applicant's summary and conclusion

Conclusions:

Doses (5000, 1500, 500, 150, and 50 µg/plate) performed from solutions of the test item, do not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA100 and in Escherichia coli WP2(uvrA-)(pKM 101) without, or with metabolic activation, according to the OECD Guidelines n°471.

Executive summary:

Solutions (GJV130617-S1 and GJ200617-S1) obtained from GV240417-1, have been tested for their capacity to induce reverse mutation in four Salmonella typhimurium strains and one Escherichia coli WP2(uvrA-)(pKM101) strain. This study was performed in the absence and presence of metabolic activation. Two independant assays were carried out.

For assay n°1, various concentrations of GJV130617-S1 were put in contact with the strains in the absence and presence of a metabolic activation system (S9 -mix 10% (v/v)).

For assay n°2, various concentrations of GJ200617-S1 were put in contact with the strains in the absence of a metabolic activation and with pre-incubation in the presence of metabolic activation system (S9-mix 10% (v/v)).

For the two assays, negative and positive controls were carried out in parallel. Positive controls induced a significant increase in the number of revertant colonies compared to negative controls. There is no significant difference between the number of spontaenous reversions, the number of reversions obtained in the positive controls (without and with metabolic activation), and the mean of corresponding experimental "histrorical" values obtained in the laboratory.

These results validate the two tests.

There is no evidence of any increase in the number of revertant colonies in the presence of the various concentration of the test item (5000, 1500, 500, 150, 50 µg/plate), without and with metabolic activation in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA100 and in Escherichia coli WP2(uvrA-)(pKM 101).

Conclusion:

Doses (5000, 1500, 500, 150, and 50 µg/plate) prepared from solutions of the test item, do not induce any mutagenic change in Salmonella typhimurium TA 1535, TA 1537, TA 98, TA100 and in Escherichia coli WP2(uvrA-)(pKM 101) without, or with metabolic activation, according to the OECD Guidelines n°471.